Characterization of a Northern German Primary Biliary Cholangitis Cohort
Zeitschrift für Gastroenterologie · 01.10.2026 · 64 (10) · 1478-1485
DOI: 10.1055/a-2857-7915 ↗Kurz gefasst
Fachartikel in der Zeitschrift Zeitschrift für Gastroenterologie, erschienen am 01.10.2026. Verfasst von Heike Bantel und 4 weiteren Autor:innen. Beteiligte Einrichtung: Hannover Medical School, Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Germany, Hannover. Hauptthemen laut MEDLINE: Liver Cirrhosis, Biliary, Obesity. Die Arbeit nennt 35 Literaturangaben.
Abstract (Originalsprache)
Real-world data on risk stratification and clinical management of patients with primary biliary cholangitis (PBC) are limited. Identification of patients with increased risk for disease progression is, however, important, since they may benefit from more stringent treatment goals and second line therapy. In this study, we retrospectively characterized a cohort of 535 PBC patients from a university hospital in northern Germany. We evaluated risk factors of disease progression, such as inadequate response to ursodeoxycholic acid (UDCA), younger age, vibration-controlled transient elastography (VCTE)-based evidence of progressed fibrosis, and co-morbidities (autoimmune hepatitis variant syndrome or obesity). The aim of this study was to get insights into the characteristics and risk factors of PBC patients which might contribute to an improved patient care. PBC was mainly diagnosed in women (92%), aged between 50 and 69 years at the time of evaluation. The majority of PBC patients were overweight and 27% revealed obesity (BMI ≥ 30 kg/m2). PBC patients with autoimmune hepatitis variant syndrome (17% in our cohort) showed a similar treatment response to ursodeoxycholic acid (according to Paris II) compared to PBC patients without a variant syndrome (55% versus 57%). Patients younger than 50 years revealed a lower treatment response rate compared to older patients (40% versus 62%). Compared to patients without advanced fibrosis, PBC patients with advanced fibrosis (VCTE values ≥ 10 kPa) had a lower treatment response (65% versus 37%). Identification of risk factors and hepatic co-morbidities is important to optimize the management and treatment of PBC patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Hannover Medical School, Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Germany, Hannover.
Zitieren
APA
Bantel, H., Kader, Y. F., John, K., Franck, M., & Wedemeyer, H. (2026). Characterization of a Northern German Primary Biliary Cholangitis Cohort. Zeitschrift für Gastroenterologie, 64(10), 1478-1485. https://doi.org/10.1055/a-2857-7915
Vancouver
Bantel H, Kader YF, John K, Franck M, Wedemeyer H. Characterization of a Northern German Primary Biliary Cholangitis Cohort. Zeitschrift für Gastroenterologie. 2026;64(10):1478-1485. doi:10.1055/a-2857-7915
BibTeX
@article{Bantel2026,
author = {Bantel, Heike and Kader, Yunus Fatih and John, Katharina and Franck, Martin and Wedemeyer, Heiner},
title = {Characterization of a Northern German Primary Biliary Cholangitis Cohort},
journal = {Zeitschrift für Gastroenterologie},
year = {2026},
volume = {64},
number = {10},
pages = {1478--1485},
doi = {10.1055/a-2857-7915}
}
EUVIMED